5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia. [electronic resource]
Producer: 20160620Description: 799-805 p. digitalISSN:- 1720-8386
- 5-alpha Reductase Inhibitors -- administration & dosage
- Acute Coronary Syndrome -- chemically induced
- Aged
- Aged, 80 and over
- Case-Control Studies
- Drug Therapy, Combination
- Dutasteride -- administration & dosage
- Finasteride -- administration & dosage
- Humans
- Male
- Middle Aged
- National Health Programs -- statistics & numerical data
- Odds Ratio
- Prostatic Hyperplasia -- drug therapy
- Risk
- Taiwan -- epidemiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.